|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Yvonne Will , James A. DykensPublisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Edition: 2nd Edition Dimensions: Width: 22.10cm , Height: 5.10cm , Length: 28.50cm Weight: 2.427kg ISBN: 9781119329701ISBN 10: 1119329701 Pages: 816 Publication Date: 11 May 2018 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationYvonne Will, PhD, is a Senior Director and the Head of Science and Technology Strategy, Drug Safety Research and Development at Pfizer, Connecticut, USA. In addition to the prior edition of this book, she co-edited Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers(Wiley, 2016). James A. Dykens, PhD, oversees EyeCyte Therapeutics, a start-up developing treatments for progressive blinding diseases via targeting mitochondrial dysfunction. He co-edited the first edition of this book. Tab Content 6Author Website:Countries AvailableAll regions |